Diet Coke’s decision to launch a slate of new flavors had some critics wondering if the company was heading for another “New Coke” disaster.
But one executive says Coca-Cola has learned from past mistakes.
“We’ve learned that when you have a great thing, you don’t mess with it,” Rafael Acevedo, the company’s North America group director, told Cheddar, pointing out that, unlike with the 1985 marketing fiasco, the classic Diet Coke isn’t going anywhere.
What is changing is the packaging -- the company introduced slimmer cans -- and the flavor options. Ginger Lime, Feisty Cherry, Zesty Blood Orange, and Twisted Mango were added to the line up.
“We’re targeting spice seekers, and we want to target those people who are trying to look for bolder flavors and new experiences,” Acevedo said. “We saw that the sleek can actually connects with the new target as well, it makes the brand feel more premium and more modern. So all the research that we have is telling us that consumers absolutely love it.”
And Diet Coke certainly did its research. The company spent over two years working on this project and talked to about 10,000 consumers to figure out what would work.
For full interview [click here](https://cheddar.com/videos/diet-coke-refreshes-itself-for-2018).
Seth Schachner, Managing Director at Strat Americas, on Hollywood's latest blockbusters utilizing content creation. Plus, the future of YouTube and TikTok.
Ashley Gold, Axios' Tech/Policy reporter, discusses what the future of Google and search engines will look like after the tech giant faces an antitrust trial.
A labor rights group has alleged that Starbucks sourced coffee from a major Brazilian cooperative whose member farms were cited for keeping workers in slave-like conditions.
X, the social media platform owned by Trump adviser Elon Musk, is challenging the constitutionality of a Minnesota ban on using deepfakes to influence elections and harm candidates.
Seth Goldstein, Equity Strategist at Morningstar, breaks down Tesla's earnings report, talks Musk's future with the company and how stocks have responded.
Senior Health Correspondent for TIME, Alice Park, gives us a deeper look into how Eli Lilly's new pill orforglipron may change the healthcare industry.
Archer Aviation CEO Adam Goldstein talks about the advancements in electric air taxis and how his company is changing the future of air transportation. Watch!